The first and only prescription cloth towelette approved to treat primary axillary hyperhidrosis in people nine-years of age and older...
· Minority-owned lab now well positioned to attract and expand institutional contracts with skilled nursing facilities, ambulatory surgery centers, schools &...
– PBGM01 advancement to clinical development represents key milestone for Passage Bio as a clinical-stage company – PHILADELPHIA, April 01, 2021...
Agios Receives $1.8 Billion in Upfront Cash to Focus on Accelerating and Expanding its Genetically Defined Disease Portfolio Agios Enters...
Leeds, UK, April 01, 2021 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) (“4D”, the “Company” or, together...
WALTHAM, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing...
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19,...
Caffeine and Vitamin D3 Infused Tauri-Gum™ Versions Tauriga Sciences, Inc. The Company is a Verified Federal Government Vendor (CAGE CODE...
STAMFORD, Conn., April 01, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing...
KIELPIN, Poland, April 01, 2021 (GLOBE NEWSWIRE) -- Celon Pharma S.A. today announced the successful completion of a Phase 1...
Basel, Switzerland, April 01, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing of the previously announced divestment...
Allschwil, Switzerland – April 1, 2021Idorsia Ltd (SIX: IDIA) today issued the formal Notice to the upcoming Annual General Meeting...
PRESS RELEASE: REGULATED INFORMATION 1 April 2021, 07:00 CEST Biocartis Announces Publication of 2020 Annual Report Mechelen, Belgium, 1 April 2021...
– Applications are supported by positive PROTECTIVE-2 Phase 3 data demonstrating that plinabulin in combination with G-CSF offers greater protection...
SAN DIEGO, March 31, 2021 (GLOBE NEWSWIRE) -- Solid tumors comprise about 90% of all newly diagnosed cancer cases and...
HALIFAX, Nova Scotia, March 31, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results...
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
SAINT LAURENT, Quebec, March 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced that, further to its...
COLUMBUS, Ohio, March 31, 2021 (GLOBE NEWSWIRE) -- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and certain of its...
FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma Sarclisa regimen...